Global Neurodiagnostic and Monitoring Devices Patent Landscape Report 2024

Global Neurodiagnostic and Monitoring Devices Market Size

The global neurodiagnostic and monitoring devices market was valued at USD 23.66 billion in 2023. It is expected to grow at a CAGR of 7.5% during the forecast period of 2024-2032 and attain a market value of USD 46.60 billion by 2032.

The market is expected to grow due to growing innovations in neurodiagnostic and monitoring technology like advanced imaging techniques and more advanced neurophysiological monitoring devices. These developments have improved the diagnostic accuracy. The neurodiagnostic and monitoring devices patent landscape is characterized by growing technological advancements and innovations signify opportunities for growth and development.

Patent Landscape Report Coverage

The Global Neurodiagnostic and Monitoring Devices Patent Landscape Report provides a comprehensive and in-depth analysis of the patents in this growing industry. The key sections captured in the report for neurodiagnostic, and monitoring devices include a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes the latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation associated with neurodiagnostic and monitoring devices. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within neurodiagnostic and monitoring devices technologies.

Key Inclusions

• Patent Valuation Analysis

An evaluation and competitive benchmarking of key members of unique patent families are covered in the analysis for neurodiagnostic and monitoring devices technologies. The important parameters have been taken into consideration including IP document, year of application, number of citations, time to expiry, and jurisdiction associated with neurodiagnostic and monitoring devices.

• Analysis of Patent Applications

A comprehensive summary of several patent applications which were filed across different jurisdictions for neurodiagnostic, and monitoring devices and their relative value are covered. The analysis will cover the capital in terms of innovation and innovation type.

• Analysis of Granted Patents

Detailed analysis of the granted patents across different jurisdictions for neurodiagnostic and monitoring devices and their relative value in the IP are covered in the final report.

Neurodiagnostic and Monitoring Devices Patent Outlook

• There is a rise in patents within the industry, which can be attributed to the rising integration of artificial intelligence and machine learning in neurodiagnostic devices. These technologies have enhanced diagnostic accuracy and enabled predictive analytics. Wearable and portable neurodiagnostic device patents are expected to grow in the coming years.

• Companies have adopted strategic partnerships, joint ventures, and licensing agreements in neurodiagnostic and monitoring devices patented technologies. Collaboration with research organizations and academic institutions is expected to drive innovation and patent activity.

• A rise in patent filings related to novel diagnostic algorithms and new sensor technologies is expected. Companies are protecting their innovations through patents to maintain a competitive edge in the market. In 2023, 21 patent applications were filed, rising from 10 applications in 2022.

What are Neurodiagnostic and Monitoring Devices?

Neurodiagnostic and monitoring devices are used to diagnose and monitor neurological conditions by evaluating the electrical, functional, and structural aspects of the nervous system. These devices help in diagnosing neurological disorders and tracking disease progression. There are several types of neurodiagnostic and monitoring devices such as electroencephalography (EEG) devices, electromyography (EMG) devices, evoked potential (EP) devices, intracranial pressure (ICP) monitors and computed tomography (CT) scanners among others.

Neurodiagnostic and monitoring devices are essential technologies in modern neurology as they offer critical insights into brain function and help in the management of neurological disorders. The market is experiencing growth due to several reasons including the rising prevalence of neurological disorders, technological advancements, expansion of indications, and growing geriatric populations among others. The global market expansion provides an opportunity for the patent companies to explore innovative products in neurodiagnostic and monitoring devices market.

Neurodiagnostic and Monitoring Devices Industry Growth Drivers

Advancement in Wearable and Portable Technologies is Expected to Boost the Patent Industry Growth

The innovations in portable EEG systems allows for continuous brain activity monitoring even outside clinical settings. The innovations include improved wireless connectivity for seamless data transfer and real-time monitoring. Also, the developments in wearable sensors and devices such as smart headbands and EEG headsets have driven the growth of the market. They offer real-time monitoring and data collection for indications like epilepsy and sleep disorders. The key features include the development of advanced sensors which provide accurate readings without the need for invasive procedures. These innovations and developments have led to an increase in patent filings by countries. In 2023, 9 patents were granted. Patents covering these technologies are crucial for companies to maintain a competitive edge in the market and thus impact the neurodiagnostic and monitoring devices patent landscape significantly.

Advanced Neuroimaging Techniques and Intellectual Property Strategies are Expected to Propel Neurodiagnostic and Monitoring Devices Patent Industry

The neurodiagnostic and monitoring devices patent industry growth is driven by continuous technical innovations. Advancements in MRI technology provide more detailed images of brain structures and functions. The development of functional near-infrared spectroscopy (fNIRS) has driven the growth of the market. This non-invasive technique helps in measuring the changes in blood oxygen levels to monitor brain activity.

Companies are developing comprehensive patent portfolios to protect their innovations and establish a strong market presence. This strategy involves filing patents for core technologies in neurodiagnostic devices. Companies are also collaborating with research and academic institutes for the development of innovative technologies. These dynamics create opportunities for additional patent filings and the exploitation of new technologies. Consequently, 21 patent applications were filed in 2023, rising from 10 applications in 2022.

Neurodiagnostic and Monitoring Devices Patent Segmentation

The report will cover the following sections in detail:

Analysis by Product Type

• Magnetic Resonance Imaging (MRI) Scanners

• Computerized Tomography (CT) Scanners

• Positron Emission Tomography (PET) Scanners

• Electroencephalograph (EEG) Devices

• Electromyography (EMG) Devices

• Intracranial Pressure (ICP) Monitors

Neurodiagnostic and Monitoring Devices Patent Segmentation Analysis

The breakup based on product type includes magnetic resonance imaging (MRI) scanners, computerized tomography (CT) scanners, positron emission tomography (PET) scanners, electroencephalograph (EEG) devices, electromyography (EMG) devices, intracranial pressure (ICP) monitors and others. Intracranial pressure (ICP) monitors are medical devices used to measure pressure inside the skull. It is crucial for managing and diagnosing conditions which affect brain pressure such as traumatic brain injury, brain tumors, and intracranial haemorrhages among others.

Detailed technological data will be provided for all specified segments classified in this report.

Neurodiagnostic and Monitoring Devices Patent Jurisdiction Analysis

The United States is one of the leading jurisdictions for neurodiagnostic and monitoring device patents, having around 235 patents. The presence of key companies, well-established healthcare infrastructure, growing innovations, rising cases of neurological disorders and advanced research and development activities contribute to the regional patent landscape significantly.

Patent Profile of Key Companies

Among the players with neurodiagnostic and monitoring devices patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the neurodiagnostic and monitoring devices field. Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:

Medtronic Inc.

Medtronic Inc. was founded in 1949 and headquartered in Ireland. The company is engaged in developing, manufacturing, and distributing several medical devices including neurodiagnostic and monitoring devices. The company is a global leader in the field of medical devices and has received patents in the field of neurodiagnostic technologies.

Brainscope Co Inc.

BrainScope Company, Inc. was founded in 2006 and is headquartered in the United States. It is a medical neuro-technology company utilizing EEG technology to evaluate the full spectrum of mild traumatic brain injury, including functional injuries, and structural injuries.

Other companies include Spinal Modulation Inc., Ovid Therapeutics Inc., Neurosigma Inc., Cerner Innovation Inc., and Univ California among others.

Reasons to Purchase this Report

The neurodiagnostic and monitoring devices patent report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by -

• Competitive Advantage: The landscape reveals the market leaders, potential partners and innovators and makes it understandable which companies have important patents in this field of neurodiagnostic and monitoring devices.

• Innovation Insights: The patent analysis reveals new innovations and technologies in neurodiagnostic and monitoring devices.

• Market Positioning: Companies with strong patent portfolios gain a competitive advantage because their intellectual property assets differentiate their products. Understanding their intellectual property strategy reveals the market position of new entrants and potential barriers to entry within the neurodiagnostic and monitoring devices patent landscape.

• Risk Assessment: In technology-intensive fields such as neurodiagnostic and monitoring devices, risks of IP infringement are common. Analyzing patent landscapes helps companies assess risk, develop mitigation strategies, and inform licensing, partnering, and acquisition decisions.

Key Questions Answered in the Neurodiagnostic and Monitoring Devices Patent Landscape Report

• Who are the key players in the neurodiagnostic and monitoring devices patent landscape?
• How is the patent portfolio distributed geographically?
• What are the emerging trends in neurodiagnostic and monitoring device patents?
• How has the patent landscape evolved over time?
• What are the strategic insights for market players and investors?
• What is the technological focus of patents in the neurodiagnostic and monitoring devices industry?
• How do patent strategies impact competitive advantage?
• What are the implications of patent filings in neurodiagnostic and monitoring devices?
• What are the challenges and opportunities in the neurodiagnostic and monitoring devices patent landscape?
• What are the regulatory and legal considerations?
• What technological innovations have recently emerged in neurodiagnostic and monitoring devices?

Related Reports

Neurodiagnostic and Monitoring Devices Market

Neurothrombectomy Devices Market

Neuromodulation Devices Market